Acute Stroke in a Patient with Mucopolysaccharidosis Type I with Increased Carotid Intima-Media Thickness
Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disease caused by a deficiency of the lysosomal enzyme alpha-L-iduronidase. Cardiovascular involvement in MPS I includes deposition of glycosaminoglycans (GAGs) in the myocardium, cardiac valves, great vessels, and coronary arteries. Although the vascular effects of GAG accumulation are well known, the clinical effects of the histopathological changes are poorly understood. Because most studies on the vascular effects of GAG accumulation are performed postmortem or with invasive techniques such as angiography, recent studies have focused on endothelial function in patients with MPS I and noninvasive techniques that may help detect vascular dysfunction. Presently described is the case of a patient with MPS type I with acute stroke and proven endothelial dysfunction.
1. de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 20116:55. [CrossRef]
2. Braunlin E, Orchard PJ, Whitley CB, Schroeder L, Reed RC, Manivel JC. Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review. Cardiovasc Pathol 2014;23:145–51. [CrossRef]
3. Wang RY, Braunlin EA, Rudser KD, Dengel DR, Metzig AM, Covault KK, et al. Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness. Mol Genet Metab 2014;111:128–32. [CrossRef]
4. Neely J, Carpenter J, Hsu W, Jordan L, Restrepo L. Cerebral infarction in Hunter syndrome. J Clin Neurosci 2006;13:1054–7.
5. Fujii D, Manabe Y, Tanaka T, Kono S, Sakai Y, Narai H, et al. Scheie syndrome diagnosed after cerebral infarction. J Stroke Cerebrovasc Dis 2012;21:330–2. [CrossRef]
6. Aydin M, Akarsu S, Kabakus N, Akpolat N. Mucopolysaccharidosis IIIB, cerebral vasculopathy and recurrent subdural hematoma. Indian Pediatr 2006;43:437–40.
7. Doyon A, Kracht D, Bayazit AK, Deveci M, Duzova A, Krmar RT, et al; 4C Study Consortium. Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension 2013;62:550–6. [CrossRef]
8. Balcerzyk A, Niemiec P, Kopyta I, Emich-Widera E, Pilarska E, Pienczk-Ręcławowicz K, et al. Methylenetetrahydrofolate reductase gene A1298C polymorphism in pediatric strokecase-control and family-based study. J Stroke Cerebrovasc Dis.2015;24:61–5. [CrossRef]
9. Kheradmand E, Pourhossein M, Amini G, Saadatnia M. Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults. Adv Biomed Res 2014;3:80.
10. Hamedani AG, Cole JW, Mitchell BD, Kittner SJ. Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment. Stroke 2010;41:1599–603.